Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > what makes anyone think that dg is happy with the sp either?

<< Previous

Bullboard Posts

Next >>

Comment by 90guppyon May 28, 2020 8:38pm

63 Views

Post# 31085521

RE:RE:RE:what makes anyone think that dg is happy with the sp either?

at 0.085 pp of course not, but vaxil needed the money and needed it bad. Mgt has to pull the trigger. This has to close quick, common M Partners, Close it. We got a good thing going on here if only you look deeper.

bigbanktheory wrote:

kevlin139 wrote:
dg is the reason tge sp is .075 he set the pp at .085 he misled his may 5 release

bigbanktheory wrote: ? any comments

maybe something happened from then till now, i have no idea, but i would hope to see some news in less than a week with hopefully something positive to say, like i said, hope to, just a guess